JPH0597903A - Polysaccharide and its production - Google Patents
Polysaccharide and its productionInfo
- Publication number
- JPH0597903A JPH0597903A JP22420191A JP22420191A JPH0597903A JP H0597903 A JPH0597903 A JP H0597903A JP 22420191 A JP22420191 A JP 22420191A JP 22420191 A JP22420191 A JP 22420191A JP H0597903 A JPH0597903 A JP H0597903A
- Authority
- JP
- Japan
- Prior art keywords
- polysaccharide
- icc
- glucose
- galactose
- cultured
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000004676 glycans Chemical class 0.000 title claims abstract description 57
- 229920001282 polysaccharide Polymers 0.000 title claims abstract description 56
- 239000005017 polysaccharide Substances 0.000 title claims abstract description 56
- 238000004519 manufacturing process Methods 0.000 title claims description 11
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 claims abstract description 20
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 claims abstract description 10
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 10
- 229940107700 pyruvic acid Drugs 0.000 claims abstract description 10
- 241000589516 Pseudomonas Species 0.000 claims abstract description 8
- 238000000034 method Methods 0.000 claims abstract description 8
- 241000894006 Bacteria Species 0.000 claims abstract description 7
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims abstract description 6
- 238000002523 gelfiltration Methods 0.000 claims abstract description 3
- 239000000470 constituent Substances 0.000 claims description 4
- 238000000862 absorption spectrum Methods 0.000 claims description 3
- 238000012258 culturing Methods 0.000 abstract description 5
- 239000002244 precipitate Substances 0.000 abstract description 5
- 239000000706 filtrate Substances 0.000 abstract description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Inorganic materials [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract description 4
- 229960001927 cetylpyridinium chloride Drugs 0.000 abstract description 2
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 abstract description 2
- 239000003349 gelling agent Substances 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- 239000011780 sodium chloride Substances 0.000 abstract description 2
- 239000002562 thickening agent Substances 0.000 abstract description 2
- GZCGUPFRVQAUEE-SLPGGIOYSA-N aldehydo-D-glucose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-SLPGGIOYSA-N 0.000 abstract 1
- 239000001963 growth medium Substances 0.000 abstract 1
- 239000000047 product Substances 0.000 abstract 1
- 238000001226 reprecipitation Methods 0.000 abstract 1
- 239000008103 glucose Substances 0.000 description 10
- 239000002609 medium Substances 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 244000005700 microbiome Species 0.000 description 7
- 229920001817 Agar Polymers 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- 229930182830 galactose Natural products 0.000 description 4
- 238000001802 infusion Methods 0.000 description 4
- 239000013587 production medium Substances 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 238000011218 seed culture Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- XJFIPJXYYUYQIC-WNJXEPBRSA-N (2R,3S,4R,5S)-2,3,4,5,6-pentahydroxy-6-methylheptanal Chemical compound CC(C)(O)[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)C=O XJFIPJXYYUYQIC-WNJXEPBRSA-N 0.000 description 2
- XJFIPJXYYUYQIC-VZFHVOOUSA-N (2R,3S,4S,5S)-2,3,4,5,6-pentahydroxy-6-methylheptanal Chemical compound CC([C@H]([C@H]([C@@H]([C@H](C=O)O)O)O)O)(O)C XJFIPJXYYUYQIC-VZFHVOOUSA-N 0.000 description 2
- ROWKJAVDOGWPAT-UHFFFAOYSA-N Acetoin Chemical compound CC(O)C(C)=O ROWKJAVDOGWPAT-UHFFFAOYSA-N 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- 108090001090 Lectins Proteins 0.000 description 2
- 102000004856 Lectins Human genes 0.000 description 2
- 102000004316 Oxidoreductases Human genes 0.000 description 2
- 108090000854 Oxidoreductases Proteins 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 235000013405 beer Nutrition 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 210000003495 flagella Anatomy 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000002523 lectin Substances 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 230000009897 systematic effect Effects 0.000 description 2
- 239000011345 viscous material Substances 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- OXIKLRTYAYRAOE-CMDGGOBGSA-N (e)-3-(1-benzyl-3-pyridin-3-ylpyrazol-4-yl)prop-2-enoic acid Chemical compound N1=C(C=2C=NC=CC=2)C(/C=C/C(=O)O)=CN1CC1=CC=CC=C1 OXIKLRTYAYRAOE-CMDGGOBGSA-N 0.000 description 1
- LDXJRKWFNNFDSA-UHFFFAOYSA-N 2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound C1CN(CC2=NNN=C21)CC(=O)N3CCN(CC3)C4=CN=C(N=C4)NCC5=CC(=CC=C5)OC(F)(F)F LDXJRKWFNNFDSA-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- FNEHAOQZWPHONV-UHFFFAOYSA-N 9h-carbazole;sulfuric acid Chemical compound OS(O)(=O)=O.C1=CC=C2C3=CC=CC=C3NC2=C1 FNEHAOQZWPHONV-UHFFFAOYSA-N 0.000 description 1
- 229920000856 Amylose Polymers 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 102100026189 Beta-galactosidase Human genes 0.000 description 1
- 102100035882 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 241000588748 Klebsiella Species 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 102100021079 Ornithine decarboxylase Human genes 0.000 description 1
- 108700005126 Ornithine decarboxylases Proteins 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 235000006089 Phaseolus angularis Nutrition 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- 108010039491 Ricin Proteins 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 108010046334 Urease Proteins 0.000 description 1
- 240000007098 Vigna angularis Species 0.000 description 1
- 235000010711 Vigna angularis Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- -1 alditol acetate Chemical class 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000000721 bacterilogical effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-FPRJBGLDSA-N beta-D-galactose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-FPRJBGLDSA-N 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 229960002086 dextran Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 239000011346 highly viscous material Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 description 1
- 125000000468 ketone group Chemical group 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 238000004816 paper chromatography Methods 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 150000004804 polysaccharides Polymers 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 229940076788 pyruvate Drugs 0.000 description 1
- 102220201851 rs143406017 Human genes 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- DTQVDTLACAAQTR-UHFFFAOYSA-N trifluoroacetic acid Substances OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は高粘性を有する新規な多
糖類およびその製造法に関するものである。FIELD OF THE INVENTION The present invention relates to a novel polysaccharide having a high viscosity and a method for producing the same.
【0002】[0002]
【従来の技術】有用多糖類としては植物起源のセルロー
ス、ペクチン、アミロースや動物起源のヘパリン、コン
ドロイチン硫酸等がよく知られている。さらにある種の
微生物が多糖類を産生することも知られており、これら
の微生物が産生する多糖類のうちヒアルロン酸、デキス
トラン、ザンタンガム、プルラン等はすでに産業上利用
され、あるいは利用されつつある。BACKGROUND OF THE INVENTION As useful polysaccharides, plant-derived cellulose, pectin, amylose, animal-derived heparin, chondroitin sulfate and the like are well known. It is also known that certain kinds of microorganisms produce polysaccharides, and among the polysaccharides produced by these microorganisms, hyaluronic acid, dextran, xanthan gum, pullulan and the like have already been or are being industrially utilized.
【0003】[0003]
【発明が解決しようとする課題】微生物が産生する種々
の多糖類には、産業上利用されているものもあるが、こ
れら公知の化合物よりも更に強力な増粘性、ゲル化能を
有する新素材の出現が常に要望されている。本発明者ら
はこれらの点に着目し、広く土壌菌を採取してその多糖
類生産能を検索し、高粘性を示す多糖類を提供すること
によって、これを解決しようとするものである。Although various polysaccharides produced by microorganisms are industrially used, new materials having a stronger thickening property and gelling ability than these known compounds are available. The emergence of is always desired. The present inventors pay attention to these points, and try to solve this problem by collecting soil fungi and searching their polysaccharide-producing ability to provide polysaccharides having high viscosity.
【0004】[0004]
【課題を解決するための手段】本発明者らは上述の要望
に応えるべく、寒天培地上に高粘性物質を産生する微生
物の探索を続けていたところ、シュードモナス属に属す
るある菌株が寒天培地上に透明なコロニーを産生するこ
とを見出し、この透明な粘性物質が新規な構造を有する
多糖類であることを明らかにすることにより本発明を完
成させた。本発明の目的は、新規高粘性多糖類ならびに
その製造法を提供することにある。[Means for Solving the Problems] In order to meet the above-mentioned demand, the inventors of the present invention continued to search for a microorganism that produces a highly viscous substance on an agar medium, and found that a strain belonging to the genus Pseudomonas was found on the agar medium. The present invention has been completed by discovering that transparent colonies were produced in and that the transparent viscous substance was a polysaccharide having a novel structure. An object of the present invention is to provide a novel highly viscous polysaccharide and a method for producing the same.
【0005】第1の本発明の要旨とするところは、グル
コース、ガラクトース、ピルビン酸を構成成分とし、高
粘性を有する多糖類を提供するものである。さらに第2
の本発明は、シュードモナス属に属し、上述の多糖類産
生能を有する微生物を培養し、その培養液から上述の多
糖類を採取することを特徴とする多糖類の製造法を提供
するものである。The gist of the first aspect of the present invention is to provide a polysaccharide having high viscosity, which comprises glucose, galactose and pyruvic acid as constituent components. And second
The present invention provides a method for producing a polysaccharide, which comprises culturing a microorganism that belongs to the genus Pseudomonas and has the above-mentioned polysaccharide-producing ability, and collecting the above-mentioned polysaccharide from the culture solution. ..
【0006】1.生産菌ICC−001株の菌学的性状 本発明に使用される微生物の一例としては、本発明者ら
によって京都府城南市の土壌より新たに分離されたIC
C−001株がある。ICC−001株の菌学的性状は
つぎのとおりである。 I.顕微鏡的形態 形態 :桿菌で胞子を形成しない。 運動性:極鞭毛で運動する 大きさ:0.6〜0.8×1.2〜2.0μm II.染色 グラム染色:陰性 III.生理的性質 酸素要求性 :絶対好気性 オキシダーゼ生成 :陽性 β−ガラクトシダーゼ生成 :陽性 オルニチンデカルボキシラーゼ生成 :陰性 ウレアーゼ生成 :陽性 トリプトファンデアミナーゼ生成 :陰性 アセチルメチルカルビノール生成 :陰性 蛍光色素の生成 :陰性 硫化水素の発生 :陰性 インドールの生成 :陰性 澱粉の加水分解能 :陰性 ゼラチンの加水分解能 :陰性 硝酸塩の還元性 :陽性 アルギニンの分解 :陰性 リジンの分解 :陰性 脱窒反応 :陰性 MRテスト :陰性 カゼインの分解 :陽性 クエン酸の利用 :陽性 カタラーゼ反応 :陽性 OFテスト :O型 以上の諸性質に従い、バージーズ・マニュアル・オブ・
システマチック・バクテリオロジー(Bergeys
Manual of SystematicBacte
riology)Vol 1により検索したところ、本
菌はグラム陰性の桿菌であり、極鞭毛で運動し、絶対好
気性で、オキシダーゼ陽性であることから本菌はシュー
ドモナス属と同定された。なおICC−001株を工業
技術院微生物工業技術研究所に寄託し、平成3年8月2
8日微工研菌寄第12453号として受託された。1. Bacteriological Properties of Producing Bacterium ICC-001 Strain As an example of the microorganism used in the present invention, IC newly isolated from soil in Jonan City, Kyoto Prefecture by the present inventors
There is C-001 strain. The mycological properties of the ICC-001 strain are as follows. I. Microscopic morphology Morphology: Bacillus does not form spores. Motility: Movement with polar flagella Size: 0.6-0.8 x 1.2-2.0 μm II. Staining Gram stain: Negative III. Physiological properties Oxygen requirement: Absolute aerobic oxidase production: Positive β-galactosidase production: Positive Ornithine decarboxylase production: Negative urease production: Positive Tryptophan deaminase production: Negative acetylmethylcarbinol production: Negative fluorescence Dye formation: Negative Hydrogen sulfide formation: Negative Indole formation: Negative Starch hydrolysis: Negative Gelatin hydrolysis: Negative Nitrate reducibility: Positive Arginine degradation: Negative Lysine degradation: Negative Denitrification: Negative MR Test: Negative Casein degradation: Positive Use of citric acid: Positive Catalase reaction: Positive OF test: O type According to the above properties, the Vergiz Manual of
Systematic Bacteriology (Bergeys)
Manual of Systematic Bacte
As a result of searching by riology) Vol 1, this bacterium was a Gram-negative bacillus, motivated by polar flagella, absolutely aerobic, and oxidase-positive, so that this bacterium was identified as Pseudomonas. The ICC-001 strain was deposited at the Institute of Microbial Technology, Institute of Industrial Technology, August 2, 1991.
It was entrusted as Microbiology Research Institute No. 12453 on 8th.
【0007】2.多糖類生産菌ICC−001株の培養
法 本発明においては、かかるシュードモナス属に属する多
糖類生産菌を培地で培養する。該培養に当たっては使用
する微生物が資化できる炭素源、窒素源、生育に必要な
各種無機塩類等の栄養源を含む培地が用いられる。具体
的には、炭素源としてはブドウ糖、蔗糖等があり、窒素
源としては肉エキス、酵母エキス、ペプトン、硫酸アン
モニウムその他の有機物あるいは無機物が用いられる。
培養はpH5.5〜9.5好ましくは6.5〜7.5、
温度15℃〜45℃好ましくは25℃〜35℃で実施さ
れ通常数日程度の培養で良い。2. Culturing Method of Polysaccharide-Producing Strain ICC-001 Strain In the present invention, the polysaccharide-producing bacterium belonging to the genus Pseudomonas is cultured in a medium. In the culturing, a medium containing a carbon source, a nitrogen source, and nutrient sources such as various inorganic salts necessary for growth that can be assimilated by the microorganism used is used. Specifically, glucose, sucrose, and the like are used as carbon sources, and meat extract, yeast extract, peptone, ammonium sulfate, and other organic or inorganic substances are used as nitrogen sources.
Culturing is performed at pH 5.5 to 9.5, preferably 6.5 to 7.5,
It is carried out at a temperature of 15 ° C. to 45 ° C., preferably 25 ° C. to 35 ° C., and usually a culture for several days may be performed.
【0008】3.ICC−001多糖の精製法 このようにして得られた培養物中には本発明の目的とす
る多糖類がふくまれている。従って該培養物中から多糖
類を抽出・生成する必要がある。該多糖類の精製に当た
っては予め培養物中の菌体や他の固形分を除去した後多
糖類を回収することが好ましい。3. Method for Purifying ICC-001 Polysaccharide The thus obtained culture contains the polysaccharide of interest of the present invention. Therefore, it is necessary to extract and generate polysaccharides from the culture. In purifying the polysaccharide, it is preferred to remove the bacterial cells and other solids in the culture in advance and then recover the polysaccharide.
【0009】精製には加熱、遠心分離、沈澱、洗浄、乾
燥等多糖類を不純物から回収するために通常使用される
手段を単独にあるいは適宜組み合わせることによって実
施すればよい。その一例を示すと、上記固形分を除去し
て得られた溶液にエタノール等の溶剤を添加して該多糖
類を析出せしめる。よって得られた多糖類を食塩を含む
水に溶解させ、再びエタノール等の溶剤により多糖類を
析出させる。この処理を繰り返し行った後、透析、凍結
乾燥することにより精製された多糖類を得ることができ
る。The purification may be carried out by heating, centrifugation, precipitation, washing, drying or the like, which is usually used for recovering the polysaccharide from impurities, alone or in combination. As an example, a solvent such as ethanol is added to the solution obtained by removing the solid content to precipitate the polysaccharide. The polysaccharide thus obtained is dissolved in water containing salt, and the polysaccharide is precipitated again with a solvent such as ethanol. After repeating this treatment, a purified polysaccharide can be obtained by dialysis and freeze-drying.
【0010】4.ICC−001多糖の物理化学的性状 このようにして得られたICC−001多糖の性質を以
下に示す。 (1)分子量 約70万(トヨパールHW65Sによるゲル濾過法で測
定) (2)比旋光度 −0.16°(c 0.4,1M NaCl) (3)赤外線吸収スペクトル 図1に示す。 (4)構成成分 ICC−001多糖を加水分解し(加水分解条件:5%
(V/V)硫酸,100℃,時間)、分解液を濃縮し薄
層クロマトグラフィー、ガスクロマトグラフィーカルバ
ゾール硫酸比色法により分析定量した。その結果D−グ
ルコース、D−ガラクトースが主要構成成分であること
がわかった。そして、それぞれの成分はモル比で約3.
3:1であった。また多糖溶液をトリフルオロ酢酸でp
H2に調整し、100℃,2.5時間加熱して弱酸分解
を行った。その後透析を行い、その外液を濃縮しペーパ
ークロマトグラフィーで分離したところ、ピルビン酸が
検出された。ピルビン酸の定量はラクトースデヒドロゲ
ナーゼを用い、ピルビン酸が乳酸に還元される際消費さ
れるNADHの量を340nmの吸収の減少を測定する
ことにより行ったところ、重量にして4%のピルビン酸
が含まれることがわかった。4. Physicochemical Properties of ICC-001 Polysaccharide The properties of the ICC-001 polysaccharide thus obtained are shown below. (1) Molecular weight of about 700,000 (measured by gel filtration method with Toyopearl HW65S) (2) Specific rotation -0.16 ° (c 0.4, 1M NaCl) (3) Infrared absorption spectrum As shown in FIG. (4) Constituents ICC-001 Polysaccharide is hydrolyzed (hydrolysis condition: 5%
(V / V) sulfuric acid, 100 ° C., hour), the decomposed solution was concentrated, and analyzed and quantified by thin layer chromatography and gas chromatography carbazole sulfuric acid colorimetric method. As a result, it was found that D-glucose and D-galactose were the main constituents. And, each component is about 3.
It was 3: 1. Also, the polysaccharide solution is p-trifluoroacetic acid.
It was adjusted to H2 and heated at 100 ° C. for 2.5 hours for weak acid decomposition. After that, dialysis was performed, and the external solution was concentrated and separated by paper chromatography, and pyruvic acid was detected. Pyruvic acid was quantified using lactose dehydrogenase, and the amount of NADH consumed when pyruvic acid was reduced to lactic acid was measured by measuring the decrease in absorption at 340 nm. As a result, pyruvic acid contained 4% by weight. I found out that
【0011】(5)結合様式 多糖の結合様式を知るために箱守法によるメチル化分析
を行った。各メチル化単糖はアルディトール アセテー
トとし、OV−1のキャピラリーカラム(0.25mm
×50m)でガスクロ分析(150℃〜230℃,2℃
/min)を行った。各ピークの同定はGC−MSと標
準サンプルとの保持時間の比較によって行った。その結
果を表1に示す。本多糖と脱ピルビン酸多糖とを比較す
ると、直鎖部分を形成する糖残基の量はあまり変化して
いない(表1(1)、(2)、(3)、(4)、
(7))。これに対しジメチルガラクトース(8)は減
少している。またガラクトースの末端残基(6)は増加
している。このことからガラクトースの4,6位にピル
ビン酸の2位のケト基がケタール結合していると考えら
れる。一方ジメチルグルコース(5)は変化していない
ことから、これがこの多糖の分岐点を形成しており、そ
れに対応してピルビン酸の結合したガラクトース残基が
枝の部分の末端に位置するものと考えられる。また脱ピ
ルビン酸多糖はβ−D−ガラクトースと特異的に結合す
るレクチン(トウアズキレクチンおよびヒマ豆レクチ
ン)と反応し沈降線を生じることから、ピルビン酸の結
合したガラクトースはβ結合していることがわかった。
さらに緩和水解(0.1Nの酸,25℃)を含むスミス
分解で、グリセロール、エリスリトールの他 2−O−
β−D−グリコシルエリスリトールが生成することか
ら、主鎖の中には →3Glcl→4Glcl→のグル
コース残基の配列が存在することが分かる。(5) Binding mode In order to know the binding mode of the polysaccharide, methylation analysis by the Hakomori method was performed. Each methylated monosaccharide was alditol acetate, and the column of OV-1 capillary (0.25 mm
Gas chromatographic analysis (150 ℃ -230 ℃, 2 ℃)
/ Min). Each peak was identified by comparing the retention times of GC-MS and the standard sample. The results are shown in Table 1. Comparing the present polysaccharide with the depyruvated polysaccharide, the amount of sugar residues forming the straight chain portion was not significantly changed (Table 1 (1), (2), (3), (4),
(7)). On the other hand, the amount of dimethylgalactose (8) is decreasing. In addition, the terminal residue (6) of galactose is increased. From this, it is considered that the keto group at the 2-position of pyruvic acid is ketal-bonded to the 4- and 6-positions of galactose. On the other hand, since dimethyl glucose (5) is unchanged, it is considered that this forms the branch point of this polysaccharide, and the galactose residue to which pyruvic acid is bound is located at the end of the branch part correspondingly. Be done. In addition, depyruvic polysaccharide reacts with lectins that specifically bind to β-D-galactose (such as azuki bean lectin and castor bean lectin) to form a precipitation line. Therefore, galactose to which pyruvate is bound is β-linked. I understood.
In addition, by smith decomposition including mild hydrolyzation (0.1N acid, 25 ° C), glycerol, erythritol and other 2-O-
Since β-D-glycosylerythritol is produced, it is found that there is a sequence of → 3Glcl → 4Glcl → glucose residues in the main chain.
【0012】[0012]
【表1】 表1 モ ル 比 O−メチル化糖 多 糖 脱ピルビン酸多糖 2,3,4,6-Me4-グルコース (1) 0.1 0.2 2,4,6-Me3-グルコース (2) 2.1 2.0 2,4,6-Me3-グルコース (3) 2.4 2.6 2,3,4-Me3-グルコース (4) 0.9 0.9 2,3-Me2-グルコース (5) 1.0 1.0 2,3,4,6-Me4-ガラクトース(6) 0.1 0.6 2,4,6-Me3-ガラクトース (7) 1.1 1.0 2,3-Me2-ガラクトース (8) 0.9 0.2 [Table 1] Table 1 Mol ratio O-methylated sugar polysaccharide Depyruvic acid polysaccharide 2,3,4,6-Me 4 -Glucose (1) 0.1 0.2 0.2 2,4,6-Me 3- Glucose (2) 2.1 2.0 2,4,6-Me 3 -Glucose (3) 2.4 2.6 2,3,4-Me 3 -Glucose (4) 0.9 0.9 2, 3-Me 2 -glucose (5) 1.0 1.0 2,3,4,6-Me 4 -galactose (6) 0.1 0.6 2,4,6-Me 3 -galactose (7) 1 1 1.0 2,3-Me 2 -galactose (8) 0.9 0.2
【0013】以上の結果から、次式に示す部分構造が推
定された。 このような部分構造を有する本多糖は、これまで知られ
ているクレブジラやE.Coli等が生産する各種のピ
ルビン酸含有多糖とは異なった多糖骨格を有する新規な
多糖類であることが判明した。From the above results, the partial structure shown in the following equation was estimated. The present polysaccharide having such a partial structure can be obtained from Klebsiella and E. It has been found that this is a novel polysaccharide having a polysaccharide skeleton different from various pyruvic acid-containing polysaccharides produced by E. coli and the like.
【0014】以下に本発明の実施例を示すが、該多糖類
の性状が本発明によって明らかにされたのでそれらの性
状にもとずき該多糖類の製造法を種々考案することがで
きる。従って本発明は実施例に限定されるものではな
く、実施例の修飾手段は勿論、本発明によって明らかに
された該多糖類の性状にもとずいて公知の手段を施して
該多糖類を生産、濃縮、抽出、精製する方法をすべて包
括する。Examples of the present invention will be shown below. Since the properties of the polysaccharide have been clarified by the present invention, various methods for producing the polysaccharide can be devised based on the properties. Therefore, the present invention is not limited to the examples, and the polysaccharides can be produced by applying known means based on the properties of the polysaccharides revealed by the present invention as well as the modifying means of the examples. It includes all methods of concentration, extraction, and purification.
【0015】[0015]
実施例1 種培地としてビールインフュージョンブロス(Veal
InfusionBroth,ディフコ社製)2.0
%、グルコース0.1%の組成からなる培地を用いた。
生産培地としては酵母エキス0.3%、肉エキス0.3
%、グルコース2.0%、寒天2.5%の組成からなる
培地を用いた。殺菌前pHはすべてpH7.0に調整し
て使用した。前記の種培地(40ml)を分注した25
0ml容三角フラスコを120℃で15分間殺菌し、I
CC−001株の斜面寒天培養の2〜3白金耳を接種
し、30℃で24時間振盪培養して種培養とした。次い
で前記の生産培地500mlを分注し約0.6cmの厚
さに固めた大型平板(35cm×35cm)に前記の種
培養液10mlを接種して30℃で24時間静置培養し
た。培養終了後、培地表面の粘性物をかきとり、濾過し
濾液を得た。Example 1 Beer infusion broth (Veal) as a seed medium
Infusion Broth, manufactured by Difco) 2.0
%, Glucose 0.1% was used as the medium.
Yeast extract 0.3%, meat extract 0.3 as production medium
%, Glucose 2.0%, agar 2.5% was used as the medium. The pH before sterilization was adjusted to pH 7.0 before use. The seed medium (40 ml) was dispensed 25
Sterilize a 0 ml Erlenmeyer flask at 120 ° C for 15 minutes.
Two to three platinum loops of a slope agar culture of CC-001 strain were inoculated and shake cultured at 30 ° C. for 24 hours for seed culture. Next, 500 ml of the above-mentioned production medium was dispensed and 10 ml of the above seed culture solution was inoculated into a large plate (35 cm × 35 cm) which was solidified to a thickness of about 0.6 cm, and static culture was carried out at 30 ° C. for 24 hours. After the culture was completed, the viscous material on the surface of the medium was scraped off and filtered to obtain a filtrate.
【0016】実施例2 生産培地としてビールインフュージョンブロス(Vea
l InfusionBroth,ディフコ社製)2.
0%、グルコース0.1%の組成からなる培地を用い
た。2L容の三角フラスコに700mlの生産培地を分
注し、120℃、15分間殺菌し、これに実施例1の如
く調製した種培養液35mlを接種して30℃、24時
間振盪培養して培養終了後培養液を濾過し濾液を得た。 実施例3 静置培養または振盪培養によって得られた培養濾液2L
に10%のセチルピリジニウムクロライド80mlを加
え、沈澱物を得た。沈澱物を遠心分離によって分け取
り、2M食塩水1Lを加えて溶解したのち3Lのエタノ
ールを加えて再び沈澱させた。沈澱物を濾取し、水1L
に溶解したのちセルロースチューブに入れ流水中で透析
したのち凍結乾燥しICC−001多糖6.6gを得
た。Example 2 Beer infusion broth (Vea) was used as a production medium.
l Infusion Broth, manufactured by Difco) 2.
A medium having a composition of 0% and glucose 0.1% was used. 700 ml of the production medium was dispensed into a 2 L Erlenmeyer flask, sterilized at 120 ° C. for 15 minutes, 35 ml of the seed culture solution prepared as in Example 1 was inoculated, and shake culture was performed at 30 ° C. for 24 hours to culture. After the completion, the culture solution was filtered to obtain a filtrate. Example 3 2 L of culture filtrate obtained by static culture or shaking culture
80 ml of 10% cetylpyridinium chloride was added to and a precipitate was obtained. The precipitate was separated by centrifugation, dissolved by adding 1 L of 2M saline solution, and then precipitated by adding 3 L of ethanol. The precipitate is collected by filtration and water 1L
It was then dissolved in the above, put into a cellulose tube, dialyzed in running water, and freeze-dried to obtain 6.6 g of ICC-001 polysaccharide.
【0017】[0017]
【発明の効果】本発明の多糖類は新規な粘性多糖類であ
り、増粘剤・ゲル化剤としての用途が期待される。The polysaccharide of the present invention is a novel viscous polysaccharide and is expected to be used as a thickener / gelling agent.
【0018】[0018]
【図1】ICC−001多糖のKBr中での赤外部吸収
スペクトルを示す。FIG. 1 shows an infrared absorption spectrum of ICC-001 polysaccharide in KBr.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.5 識別記号 庁内整理番号 FI 技術表示箇所 C12R 1:38) (72)発明者 武部 英日 横浜市港北区師岡町760番地 明治製菓株 式会社薬品総合研究所内─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 5 Identification code Internal reference number FI Technical display location C12R 1:38) (72) Inventor Hidebe Takebe Meiji Confectionery Co., Ltd. 760 Shimooka-cho, Kohoku-ku, Yokohama Company Pharmaceutical Research Institute
Claims (2)
(ICC−001多糖)。 (1)分子量: 約70万(ゲル濾過法) (2)比旋光度: −0.16°(c0.4 1M NaC
l) (3)赤外線吸収スペクトル: 図1 (4)主要構成成分がD−グルコース、D−ガラクトー
ス、ピルビン酸からなり、D−グルコースとD−ガラク
トースのモル比が約3.3:11. A highly viscous polysaccharide (ICC-001 polysaccharide) having the following physicochemical properties. (1) Molecular weight: about 700,000 (gel filtration method) (2) Specific rotation: -0.16 ° (c0.4 1M NaC
l) (3) Infrared absorption spectrum: Fig. 1 (4) Main constituent components are D-glucose, D-galactose and pyruvic acid, and the molar ratio of D-glucose and D-galactose is about 3.3: 1.
C−001多糖を産生する細菌を培養し、その培養物か
らICC−001多糖を採取することを特徴とする請求
項1記載の多糖類の製造法2. An IC that belongs to the genus Pseudomonas and is extracellular
The method for producing a polysaccharide according to claim 1, wherein a bacterium that produces C-001 polysaccharide is cultured, and ICC-001 polysaccharide is collected from the culture.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP22420191A JPH0597903A (en) | 1991-09-04 | 1991-09-04 | Polysaccharide and its production |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP22420191A JPH0597903A (en) | 1991-09-04 | 1991-09-04 | Polysaccharide and its production |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH0597903A true JPH0597903A (en) | 1993-04-20 |
Family
ID=16810113
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP22420191A Pending JPH0597903A (en) | 1991-09-04 | 1991-09-04 | Polysaccharide and its production |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0597903A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010523789A (en) * | 2007-04-11 | 2010-07-15 | 73100−セテンタ イ トレス ミル イ セン,エリデーアー | Polysaccharide rich in galactose, its production method and its application |
-
1991
- 1991-09-04 JP JP22420191A patent/JPH0597903A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010523789A (en) * | 2007-04-11 | 2010-07-15 | 73100−セテンタ イ トレス ミル イ セン,エリデーアー | Polysaccharide rich in galactose, its production method and its application |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4575551A (en) | Acidic heteropolysaccharide AM-2 | |
| JPH0138476B2 (en) | ||
| JPH0597903A (en) | Polysaccharide and its production | |
| JP2654825B2 (en) | Novel cyclic inulooligosaccharide and method for producing the same | |
| EP0247899B1 (en) | Substance useful as a thickening agent and/or emulsion stabilizer | |
| JP4300266B2 (en) | Method for producing novel polymer substance APR-3 and method for preserving producing bacteria | |
| JP5090805B2 (en) | Novel microorganism, method for decomposing hyaluronic acid or salts thereof using novel microorganism, and method for producing unsaturated hyaluronic acid sugar chain using novel microorganism | |
| JP2691838B2 (en) | BS-2 substance and method for producing the same | |
| JP4523909B2 (en) | Acid heteropolysaccharide AX-1 | |
| Stredansky et al. | Fed-batch production and simple isolation of succinoglycan from Agrobacterium tumefaciens | |
| JP3057221B2 (en) | Novel polysaccharide having unique viscosity characteristics and method for producing the same | |
| JP2693789B2 (en) | Polysaccharide and method for producing the same | |
| JP2674852B2 (en) | Levan manufacturing method | |
| JPS6339589A (en) | Hydrolysis of alginic acid or salts thereof | |
| JPH022881B2 (en) | ||
| JP2593147B2 (en) | Medium composition for protective antigen-producing bacteria | |
| JPH0823992A (en) | Method for producing hyaluronic acid | |
| JPH06197783A (en) | New cyclic isomaltooligosaccharide and its production | |
| JPS61239897A (en) | Production of polysaccharide | |
| JPH06313001A (en) | Bs-5 substance | |
| JPH0224281B2 (en) | ||
| EP0255405A1 (en) | Production of heat-modified heteropolysaccharides | |
| JPH07506975A (en) | Heteropolysaccharide 35-80 | |
| JPH0873503A (en) | Xanthan gum recovery and purification method | |
| JPH0812702A (en) | Polysaccharide and its production |